David Hoey

What if vaccination was as simple as applying a patch to the skin?

Share This Talk

Have a suggestion for The Hive?
Submit a Nomination Today

About David Hoey

David Hoey, CEO, has more than 25 years of executive-level experience in business development, licensing, strategic planning, and financing for technology companies. His experience spans preclinical and clinical development of therapeutics and vaccines, and molecular diagnostic assays and platforms. Mr. Hoey has completed over $425 million in corporate partnering transactions and equity financings in the United States, Europe, and Japan and has secured extensive contracts for government sponsored research. Mr. Hoey is a board member of publicly listed Universal Biosensors Pty. Ltd.

Find out more

About This Idea

David Hoey, CEO at Vaxxas, explains how infrastructural challenges limit the access and efficacy of traditional liquid vaccine delivery in certain regions of our world. Watch David’s TEDMED Hive 2018 Talk to hear how a revolutionary vaccine patch can deliver vaccines more safely and widely to save millions of lives.

Find out more

More Talks from the Hive

These talks are all a part of special session at TEDMED, called "Audacious" where we invite our innovators to take the stage and share the central idea they are working on, in short 2-minute talks. These talks are creatively grouped by 4 mini-segments, that serves as a creative link between each talk. To find out more visit The Hive page.